SCHEMBL5795640

SCHEMBL5795640

CCOc1ccc(CN2C[C@@H]3[C@@H](COCCCN4CCCCC4)[C@@H]3C2)cc1

nearest known ligand 0.59

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 17/20 0.59
ACHE P22303 3/20 0.58
RAD52 P43351 1/20 0.58
TSHR P16473 1/20 0.52
KDM4E B2RXH2 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5795634 1.00 HRH3 (0.59) HRH3ACHERAD52TSHRKDM4E
SCHEMBL5795639 1.00 HRH3 (0.59) HRH3ACHERAD52TSHRKDM4E
SCHEMBL5796592 0.94 HRH3 (0.62) HRH3ACHERAD52TSHR
SCHEMBL5796594 0.94 HRH3 (0.62) HRH3ACHERAD52TSHR
SCHEMBL5796590 0.94 HRH3 (0.62) HRH3ACHERAD52TSHR
SCHEMBL5795664 0.93 HRH3 (0.61) HRH3ACHERAD52TSHR
SCHEMBL5795661 0.93 HRH3 (0.61) HRH3ACHERAD52TSHR
SCHEMBL5795665 0.93 HRH3 (0.61) HRH3ACHERAD52TSHR
SCHEMBL5908120 0.92 HRH3 (0.60) HRH3ACHERAD52TSHR
SCHEMBL5793702 0.92 HRH3 (0.60) HRH3ACHERAD52TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006024955-A1 AZABICYCLIC AMINE HISTAMINE-3 RECEPTOR ANTAGONISTS PFIZER PRODUCTS INC. (US) 2006-03-09 WO claimed
US-20060047114-A1 Azabicyclic amine histamine-3 receptor antagonists PFIZER INC 2006-03-02 US claimed
WO-2006024955-A1 AZABICYCLIC AMINE HISTAMINE-3 RECEPTOR ANTAGONISTS PFIZER PRODUCTS INC. (US) 2006-03-09 WO disclosed
US-20060047114-A1 Azabicyclic amine histamine-3 receptor antagonists PFIZER INC 2006-03-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047114-A1 Azabicyclic amine histamine-3 receptor antagonists HRH3, HRH4, HRH2 HRH3 1/4885ACHE 227/4885RAD52 4180/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.